GT Biopharma Other Assets

GT Biopharma (GTBP) currently reports a other assets of $830K as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore GT Biopharma's other assets history and peer comparisons.

GT Biopharma's other assets changed from $0 to $830K (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GT Biopharma reported $830K in other assets as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other assets of $830K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GT Biopharma, and consider following GTBP for alerts when major investors trade the stock.

GT Biopharma is classified in the Healthcare sector. On other assets, it currently shows $830K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GTBP with unrelated industries.